H e m a t o lo g y E d u c a t io n - European Hematology Association
H e m a t o lo g y E d u c a t io n - European Hematology Association
H e m a t o lo g y E d u c a t io n - European Hematology Association
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
16 th Congress of the <strong>European</strong> Hemato<strong>lo</strong>gy Associat<strong>io</strong>n<br />
case-control study. Bone. 1998 Jan;22(1):67-71.<br />
38. Schulte CM, Beelen DW. Avascular osteonecrosis after al<strong>lo</strong>geneic<br />
hematopoietic stem-cell transplantat<strong>io</strong>n: diagnosis and<br />
gender matter. Transplantat<strong>io</strong>n. 2004 Oct 15;78(7):1055-63.<br />
39. Socie G, Cahn JY, Carme<strong>lo</strong> J, Vernant JP, Jouet JP, Ifrah N, et al.<br />
Avascular necrosis of bone after al<strong>lo</strong>geneic bone marrow<br />
transplantat<strong>io</strong>n: analysis of risk factors for 4388 patients by<br />
the Societe Francaise de Greffe de Moelle (SFGM). Br J<br />
Haematol. 1997 Jun;97(4):865-70.<br />
40. Campbell S, Sun CL, Kurian S. Predictors of avascular necrosis<br />
of bone in <strong>lo</strong>ng-term survivors of hematopoietic cell transplantat<strong>io</strong>n.<br />
Cancer. 2009;115(18): 4127-35.<br />
41. Schimmer AD, Minden MD, Keating A. Osteoporosis after<br />
b<strong>lo</strong>od and marrow transplantat<strong>io</strong>n: clinical aspects. B<strong>io</strong>l B<strong>lo</strong>od<br />
Marrow Transplant. 2000;6(2A):175-81.<br />
42. Weilbaecher KN. Mechanisms of osteoporosis after<br />
hematopoietic cell transplantat<strong>io</strong>n. B<strong>io</strong>l B<strong>lo</strong>od Marrow<br />
Transplant. 2000;6(2A):165-74.<br />
43. Socie G, Mary JY, Esperou H, Robert DV, Aractingi S, Ribaud<br />
P, et al. Health and funct<strong>io</strong>nal status of adult recipients 1 year<br />
after al<strong>lo</strong>geneic haematopoietic stem cell transplantat<strong>io</strong>n. Br J<br />
Haematol. 2001 Apr;113(1):194-201.<br />
44. Stern JM, Sullivan KM, Ott SM, Seidel K, Fink JC, Longton G,<br />
et al. Bone density <strong>lo</strong>ss after al<strong>lo</strong>geneic hematopoietic stem<br />
cell transplantat<strong>io</strong>n: a prospective study. B<strong>io</strong>l B<strong>lo</strong>od Marrow<br />
Transplant. 2001;7(5):257-64.<br />
45. Belkacemi Y, Labopin M, Vernant JP, Prentice HG, Tichelli A,<br />
Schattenberg A, et al. Cataracts after total body irradiat<strong>io</strong>n and<br />
bone marrow transplantat<strong>io</strong>n in patients with acute leukemia<br />
in complete remiss<strong>io</strong>n: a study of the <strong>European</strong> Group for<br />
B<strong>lo</strong>od and Marrow Transplantat<strong>io</strong>n. Int J Radiat Oncol B<strong>io</strong>l<br />
Phys. 1998 Jun 1;41(3):659-68.<br />
46. Tichelli A, Gratwohl A, Egger T, Roth J, Prunte A, Nissen C, et<br />
al. Cataract Format<strong>io</strong>n after Bone Marrow Transplantat<strong>io</strong>n.<br />
Ann Intern Med. 1993 Dec 15;119(12):1175-80.<br />
47. Socie G, Clift RA, Blaise D, Devergie A, Ringden O, Martin PJ,<br />
et al. Busulfan plus cyc<strong>lo</strong>phosphamide compared with totalbody<br />
irradiat<strong>io</strong>n plus cyc<strong>lo</strong>phosphamide before marrow transplantat<strong>io</strong>n<br />
for mye<strong>lo</strong>id leukemia: <strong>lo</strong>ng-term fol<strong>lo</strong>w-up of 4<br />
randomized studies. B<strong>lo</strong>od. 2001 Dec 15;98(13):3569-74.<br />
48. Schubert MM, Correa ME. Oral graft-versus-host disease.<br />
Dent Clin North Am. 2008 Jan;52(1):79-109.<br />
49. Nagler R, Marmary Y, Krausz Y, Chisin R, Markitziu A, Nagler<br />
A. Major salivary gland dysfunct<strong>io</strong>n in human acute and<br />
chronic graft-versus-host disease (GVHD). Bone Marrow<br />
Transplant. 1996 Feb;17(2):219-24.<br />
50. Flynn CM, Kaufman DS. Donor cell leukemia: insight into<br />
cancer stem cells and the stem cell niche. B<strong>lo</strong>od. 2007 Apr<br />
1;109(7):2688-92.<br />
51. Sala-Torra O, Hanna C, Loken MR, F<strong>lo</strong>wers ME, Maris M,<br />
Ladne PA, et al. Evidence of donor-derived hemato<strong>lo</strong>gic malignancies<br />
after hematopoietic stem cell transplantat<strong>io</strong>n. B<strong>io</strong>l<br />
B<strong>lo</strong>od Marrow Transplant. 2006 May;12(5):511-7.<br />
52. Landgren O, Gilbert ES, Rizzo JD, Socie G, Banks PM,<br />
Sobocinski KA, et al. Risk factors for lymphoproliferative disorders<br />
after al<strong>lo</strong>geneic hematopoietic cell transplantat<strong>io</strong>n.<br />
B<strong>lo</strong>od. 2009 May 14;113(20):4992-5001.<br />
53. Ades L, Guard<strong>io</strong>la P, Socie G. Second malignancies after al<strong>lo</strong>geneic<br />
hematopoietic stem cell transplantat<strong>io</strong>n: new insight<br />
and current problems. B<strong>lo</strong>od Rev. 2002 Jun;16(2):135-46.<br />
54. Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H, et<br />
al. Long-term outcome after bone marrow transplantat<strong>io</strong>n for<br />
severe aplastic anemia. B<strong>lo</strong>od. 2004 Apr 1;103(7):2490-7.<br />
55. Bhatia S, Louie AD, Bhatia R, O’Donnell MR, Fung H,<br />
Kashyap A, et al. Solid cancers after bone marrow transplantat<strong>io</strong>n.<br />
J Clin Oncol. 2001 Jan 15;19(2):464-71.<br />
56. Cohen A, Rovelli A, Mer<strong>lo</strong> DF, Van Lint MT, Lanino E, Bresters<br />
D, et al. Risk for secondary thyroid carcinoma after hematopoi-<br />
etic stem-cell transplantat<strong>io</strong>n: an EBMT Late Effects Working<br />
Party Study. J Clin Oncol. 2007 Jun 10;25(17):2449-54.<br />
57. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis<br />
LB, et al. Solid cancers after bone marrow transplantat<strong>io</strong>n. N<br />
Engl J Med. 1997 Mar 27;336(13):897-904.<br />
58. Curtis RE, Metayer C, Rizzo JD, Socie G, Sobocinski KA,<br />
F<strong>lo</strong>wers ME, et al. Impact of chronic GVHD therapy on the<br />
deve<strong>lo</strong>pment of squamous-cell cancers after hematopoietic<br />
stem-cell transplantat<strong>io</strong>n: an internat<strong>io</strong>nal case-control study.<br />
B<strong>lo</strong>od. 2005 May 15;105(10):3802-11.<br />
59. Friedman DL, Rovo A, Leisenring W, Locasciulli A, F<strong>lo</strong>wers<br />
ME, Tichelli A, et al. Increased risk of breast cancer among survivors<br />
of al<strong>lo</strong>geneic hematopoietic cell transplantat<strong>io</strong>n: a<br />
report from the FHCRC and the EBMT-Late Effect Working<br />
Party. B<strong>lo</strong>od. 2008 Jan 15;111(2):939-44.<br />
60. Kolb HJ, Socie G, Duell T, Van Lint MT, Tichelli A, Apperley<br />
JF, et al. Malignant neoplasms in <strong>lo</strong>ng-term survivors of bone<br />
marrow transplantat<strong>io</strong>n. Late Effects Working Party of the<br />
<strong>European</strong> Cooperative Group for B<strong>lo</strong>od and Marrow<br />
Transplantat<strong>io</strong>n and the <strong>European</strong> Late Effect Project Group.<br />
Ann Intern Med. 1999 Nov 16;131(10):738-44.<br />
61. Leisenring W, Friedman DL, F<strong>lo</strong>wers ME, Schwartz JL, Deeg HJ.<br />
Nonmelanoma skin and mucosal cancers after hematopoietic<br />
cell transplantat<strong>io</strong>n. J Clin Oncol. 2006 Mar 1;24(7):1119-26.<br />
62. Socie G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH,<br />
Travis LB, et al. New malignant diseases after al<strong>lo</strong>geneic marrow<br />
transplantat<strong>io</strong>n for childhood acute leukemia. J Clin<br />
Oncol. 2000 Jan;18(2):348-57.<br />
63. Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z,<br />
Horowitz MM, et al. Secondary solid cancers after al<strong>lo</strong>geneic<br />
hematopoietic cell transplantat<strong>io</strong>n using busulfan-cyc<strong>lo</strong>phosphamide<br />
condit<strong>io</strong>ning. B<strong>lo</strong>od. 2011 Jan 6;117(1):316-22.<br />
64. Rizzo JD, Curtis RE, Socie G, Sobocinski KA, Gilbert E,<br />
Landgren O, et al. Solid cancers after al<strong>lo</strong>geneic hematopoietic<br />
cell transplantat<strong>io</strong>n. B<strong>lo</strong>od. 2009 Jan 29;113(5):1175-83.<br />
65. Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont<br />
JL, Brady MJ, et al. Long-term health-related quality of life,<br />
growth, and spiritual well-being after hematopoietic stem-cell<br />
transplantat<strong>io</strong>n. J Clin Oncol. 2005 Jan 20;23(3):599-608.<br />
66. Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B, et al.<br />
Quality of life and social integrat<strong>io</strong>n after al<strong>lo</strong>geneic hematopoietic<br />
SCT. Bone Marrow Transplant. 2008 Dec;42(12):819-27.<br />
67. Kiss TL, Abdolell M, Jamal N, Minden MD, Lipton JH,<br />
Messner HA. Long-term medical outcomes and quality-of-life<br />
assessment of patients with chronic mye<strong>lo</strong>id leukemia fol<strong>lo</strong>wed<br />
at least 10 years after al<strong>lo</strong>geneic bone marrow transplantat<strong>io</strong>n.<br />
J Clin Oncol. 2002 May 1;20(9):2334-43.<br />
68. Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, F<strong>lo</strong>wers<br />
ME, et al. Recovery and <strong>lo</strong>ng-term funct<strong>io</strong>n after hematopoietic<br />
cell transplantat<strong>io</strong>n for leukemia or lymphoma. JAMA.<br />
2004 May 19;291(19):2335-43.<br />
69. Duell T, Van Lint MT, Ljungman P, Tichelli A, Socie G,<br />
Apperley JF, et al. Health and funct<strong>io</strong>nal status of <strong>lo</strong>ng-term<br />
survivors of bone marrow transplantat<strong>io</strong>n. EBMT Working<br />
Party on Late Effects and EULEP Study Group on Late Effects.<br />
<strong>European</strong> Group for B<strong>lo</strong>od and Marrow Transplantat<strong>io</strong>n. Ann<br />
Intern Med. 1997;126: 184-92.<br />
70. Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski<br />
MA, Brady MJ, et al. Late effects of cancer and hematopoietic<br />
stem-cell transplantat<strong>io</strong>n on spouses or partners compared<br />
with survivors and survivor-matched controls. J Clin Oncol.<br />
2007 Apr 10;25(11):1403-11.<br />
71. Yi JC, Syrjala KL. Sexuality after hematopoietic stem cell transplantat<strong>io</strong>n.<br />
Cancer J. 2009 Jan;15(1):57-64.<br />
| 348 | Hemato<strong>lo</strong>gy Educat<strong>io</strong>n: the educat<strong>io</strong>n programme for the annual congress of the <strong>European</strong> Hemato<strong>lo</strong>gy Associat<strong>io</strong>n | 2011; 5(1)
Change language